维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Mesters R M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Improving motion and orientation estimation using an equilibrated total least squares approach显示文摘	Mester R Mühlich M	2001	ICIP(Greece)2001，，：	1
2	UV vapor generation for determination of selenium by heated quartz tube atomic absorption spectrometry显示文摘	Guo X M Sturgeon R E Mester Z	2003	Analytical Chemistry2003，75，9：	1
3	Vapor generation by UV irradiation for sample introduction with atomic spectrometry显示文摘	Guo X M Sturgeon R E Mester Z	2004	Analytical Chemistry2004，76，8：	1
4	STEP(satellite test of the equivalence principle)显示文摘	Sumner T J Anderson J Blaser J P Cruise A M Damour T Dittus D Everitt C W F Fou-lon B Jafry Y Kent B J Lockerbie N Loeffler F Mann G Mester J Pegrum C ReinhardtR Sandford M Scheicher A Speake C C Torii R Theil S Touboul P Vitale S Vodel W Worden P W	2007	Advance in Space Re-search2007，39，2：	1
5	Monitored anesthesia care with a combination of ketamine and dexmedetomidine during cardiac catheterization显示文摘	MESTER R EASLEY B BRAY K M	2008	Am J Ther2008，15，：	1
6	Factor Ⅶa and antithrombinⅢ activity during severe sepsis and septic shock in neutropenic patients显示文摘	Mesters R M Mannucci P M Coppola R	1996	Blood1996，88，：	1
7	Nanobacteria, HIV and magic bullets--update of perspectives 2005 显示文摘	Sommer A P Milankovits M Mester A R	2006	Chemotherapy2006，52，2：	1
8	Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia 显示文摘	Ruiz S Bieker R Burger H Steins M Kienast J Buchner T Berdel WE Mesters RM	2000	Blood2000，95，8：	1
9	Satble remission after administration of thereceptor tyrosine kinase inhibitor SU5416in a patient with refratory acute myeloid leukemia显示文摘	Mesters R M Padro T Bicker R	2001	Blood2001，1998，1：	1
10	Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications 显示文摘	Mesters R M Helterbrand J Utterback B G	2000	Crit Care Med2000，28，7：	1
11	Biocompatibility and blood-aqueous barrier impairment in atrisk eyes with heparin-surface-modified or unmodified lenses显示文摘	Mester U Strauss M Grewing R	1998	J Cataract Refract Surg1998，24，3：	1
12	Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications显示文摘	Mesters R M Helterbrand J Utterback B G	2000	Girt Care Med2000，28，：	1
13	Factor Ⅶa and antithrombin Ⅲ activity during severe sepsis and septic shock in neutropenic patients显示文摘	Mesters R M Mannucci P M Coppola R	1996	Blood1996，88，3：	1
14	Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications显示文摘	MESTERS R M HELTERBRAND J UTrERBACK B G	2000	Crit Care Med2000，28，7：	1
15	Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma显示文摘	Dankbar B Padro T Leo R Feldmann B Kropff M Mesters RM	2000	Blood2000，95，8：	1
16	Synergism between the GTPase activities of EF-Tu· GTP and EF-G· GTP on empty ribosomes-elongation factors as stimulators of the ribosomal oscillation between two conformations 显示文摘	Mesters J R Potapov A P Degraaf J M	1994	J Mol Biol1994，242，：	1
17	BiocomPatibility and blood- aqueous barrier imPairment in at - risk eyes with heParin - surface - modified or unmodified lenses显示文摘	Mester U Strauss M Grewing R	1998	J Cataract Refract Surg1998，24，3：	1
18	Biocompatibility and blood-aqueous barrier impairment in at-risk eyes with heparin-surface-modified or unmodified lenses显示文摘	Mester U Strauβ M Grewing R	1998	Cataract Refract Surg1998，24，：	1
19	Parafin alkylation using zeolite catalysis in a slurry reactor: Chemical engineering principles to extend catalyst lifetime 显示文摘	JONG K R MESTERS C M PEFEROEN D G	1996	Chemical Engineering Science1996，51，10：	1
20	Biocompatibility and blood-aqueous barrier impairment in at-risk eyes with heparin-surface-modified or unmodified lenses显示文摘	Mester U Strauss M Grewing R	1998	J Cataract Refract Surg1998，24，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示